Skip to main content
Premium Trial:

Request an Annual Quote

Mark Meyers, Mary Holland


EraGen Biosciences has hired Mark Meyers and Mary Holland as vice presidents of sales and marketing. In his new position, Meyers will build partnerships around EraGen’s Master Catalog platform, an interpretive proteomics system based on an evolutionary analysis of protein families. It can be used to determine model organisms and for drug target identification. Before joining EraGen, Meyers was vice president of sales for Scimagix.

Meantime, in her new position, Holland will be responsible for EraGen’s Aegis synthetic DNA platform. Before joining EraGen, Holland was the senior director of worldwide corporate accounts for Nanogen.

Filed under

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more